Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Castleman Disease Angiolymphoid Hyperplasia with Eosinophilia Eosinophilia Granuloma Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Leukocyte Disorders Lymphatic Diseases Lymphoproliferative Disorders Skin Diseases Skin and Connective Tissue Diseases Surgery Unicentric Castleman Disease

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with unicentric form of Castleman disease
underwent surgery resection

Exclusion criteria

multilocalised Castleman disease

Treatment and study plan

surgery type/exstirpation/debulking

Procedure

Evaluation of benefit according to surgery

Primary outcomes

5 year survival

Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression

surgery treatment success
recurence rate

Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression

surgery treatment success

Sponsors and collaborators

Lead sponsor

Charles University, Czech Republic

Other

Registry information

Official study title

Castleman Disease - Diagnosis and Surgery

Important dates

Study start: 2011
Primary completion: 2021
Study completion: 2022
First posted: Jun 30, 2022
Registry last updated: Jun 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed